M&T Bank’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

M&T Bank’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,065	Closed	-$337K	–	1695
2023 Q4	$337K	Buy	+1,065	New	+$207K	﹤0.01%	1273

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

M&T Bank's KRTX Position: Q1 2024 in Review

M&T Bank sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 1,065 shares — an estimated $337K sold.

M&T Bank first reported a position in KRTX in Q4 2023 and held it in 1 quarter. The position peaked at $337K in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

M&T Bank reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
M&T Bank sold 1,065 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $337K.
M&T Bank first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
M&T Bank's Karuna Therapeutics, Inc. Common Stock position peaked at $337K in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on M&T Bank's 13F filing for Q1 2024, filed 7 May 2024.